A Study Evaluating HC-1119 Single-Dose Pharmacokinetics and Effect of Food on Its Pharmacokinetics
Status:
Completed
Trial end date:
2018-07-03
Target enrollment:
Participant gender:
Summary
This is a phase I study evaluating HC-1119 single-dose pharmacokinetics and effect of food on
its pharmacokinetics in healthy Chinese adults. The study primary objective is to evaluate
the HC-1119 pharmacokinetic characteristics and the effect of food on its pharmacokinetics in
healthy Chinese males, subsequent to a single oral administration of HC-1119 with different
doses in healthy Chinese males.
Phase:
Phase 1
Details
Lead Sponsor:
Hinova Pharmaceuticals Inc. Sichuan Haisco Pharmaceutical Group Co., Ltd.